92 related articles for article (PubMed ID: 21600257)
1. Antinociceptive properties of nasal delivery of neurotoxin-loaded nanoparticles coated with polysorbate-80.
Ruan Y; Yao L; Zhang B; Zhang S; Guo J
Peptides; 2011 Jul; 32(7):1526-9. PubMed ID: 21600257
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.
Ruan Y; Yao L; Zhang B; Zhang S; Guo J
Drug Dev Ind Pharm; 2012 Jan; 38(1):123-8. PubMed ID: 21721852
[TBL] [Abstract][Full Text] [Related]
3. [Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier].
Zhao YM; Xia AX; Wei YH; Ruan YP; Li FZ
Yao Xue Xue Bao; 2010 Oct; 45(10):1312-6. PubMed ID: 21348312
[TBL] [Abstract][Full Text] [Related]
4. Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study.
Cheng Q; Feng J; Chen J; Zhu X; Li F
Biopharm Drug Dispos; 2008 Nov; 29(8):431-9. PubMed ID: 18837064
[TBL] [Abstract][Full Text] [Related]
5. In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles.
Liu H; Ni J; Wang R
Pharmazie; 2006 May; 61(5):450-2. PubMed ID: 16724544
[TBL] [Abstract][Full Text] [Related]
6. [The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles].
Aliautdin RN; Petrov VE; Langer K; Berthold A; Kreuter J; Kharkevich DA
Eksp Klin Farmakol; 1998; 61(1):17-20. PubMed ID: 9575405
[TBL] [Abstract][Full Text] [Related]
7. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive properties of acetylenic thiophene and furan derivatives: evidence for the mechanism of action.
Goncales CE; Araldi D; Panatieri RB; Rocha JB; Zeni G; Nogueira CW
Life Sci; 2005 Mar; 76(19):2221-34. PubMed ID: 15733937
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
[TBL] [Abstract][Full Text] [Related]
11. [Effect of borneol/mentholum eutectic mixture on nasal-brain delivery of neurotoxin loaded nanoparticles].
Chai G; Pan Y; Li F
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):698-701. PubMed ID: 19624007
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA
J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201
[TBL] [Abstract][Full Text] [Related]
13. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.
Zhang X; Liu L; Chai G; Zhang X; Li F
Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853
[TBL] [Abstract][Full Text] [Related]
14. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
[TBL] [Abstract][Full Text] [Related]
15. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
[TBL] [Abstract][Full Text] [Related]
16. Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.
Al-Ghananeem AM; Saeed H; Florence R; Yokel RA; Malkawi AH
J Drug Target; 2010 Jun; 18(5):381-8. PubMed ID: 20001275
[TBL] [Abstract][Full Text] [Related]
17. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
Patil GB; Surana SJ
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
[TBL] [Abstract][Full Text] [Related]
18. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
Kreuter J; Hekmatara T; Dreis S; Vogel T; Gelperina S; Langer K
J Control Release; 2007 Mar; 118(1):54-8. PubMed ID: 17250920
[TBL] [Abstract][Full Text] [Related]
19. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
Rempe R; Cramer S; Hüwel S; Galla HJ
Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
